Nuvectis Pharma (NVCT) Q3 2023 Earnings

8NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.48
-0.32
-0.16
0

Details

Expected EPS
-0.34
Actual EPS
-0.37
Surprise EPS
-0.03
Surprise Percent
+8.82%

Description

Nuvectis Pharma (NVCT) has reported earnings of -0.37 per share for Q3 2023.

0 Comments

Share your thoughts